Gilead Sciences
GILD
#104
Rank
C$259.70 B
Marketcap
C$209.45
Share price
1.82%
Change (1 day)
28.52%
Change (1 year)

EPS for Gilead Sciences (GILD)

EPS in 2026 (TTM): C-$3.90

According to Gilead Sciences's latest financial reports the company's current EPS (TTM) is C-$3.71. In 2025 the company made an earnings per share (EPS) of C$9.77 an increase over its 2024 EPS that were of C$0.54.

EPS history for Gilead Sciences from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$3.90-139.94%
2025C$9.771702.63%
2024C$0.54-91.65%
2023C$6.4923.98%
2022C$5.23-25.86%
2021C$7.064850%
2020C$0.14-97.64%
2019C$6.050.9%
2018C$5.9918.71%
2017C$5.05-64.88%
2016C$14.38-18.45%
2015C$17.6355.28%
2014C$11.35296.02%
2013C$2.8717.89%
2012C$2.43

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$12.46-435.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$1.08-129.23%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
C$5.09-237.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$42.62-1,249.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$23.13-723.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$8.10-318.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
C$7.72-308.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
C$24.72-766.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$1.80-148.67%๐Ÿ‡บ๐Ÿ‡ธ USA